Back
Eaton Vance Enhanced Equity Income Fund II Vs. Insmed Industry Stock Comparison
Buy
73
EOS
Eaton Vance Enhanced Equity Income Fund II
Last Price:
21.63
Seasonality Move:
0.56%
Buy
65
INSM
Insmed
Last Price:
72.22
Seasonality Move:
4.27%
Buy
73
Eaton Vance Enhanced Equity Income Fund II (EOS)
is a Buy
Is Eaton Vance Enhanced Equity Income Fund II a Buy, Sell or Hold?
- The current Eaton Vance Enhanced Equity Income Fund II [EOS] share price is $21.66. The Score for EOS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- EOS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $72.28. The Score for INSM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EOS Stock Price Chart
What is Eaton Vance Enhanced Equity Income Fund II's stock price today?
-
The Eaton Vance Enhanced Equity Income Fund II share price today is $21.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EOS is experiencing buying pressure, which is a positive indicator for future bullish movement.
INSM Stock Price Chart
EOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 55.41 | Buy |
| Chaikin Money Flow: | 81417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.08 - 21.7) | Buy |
| Bollinger Bands (100): | (20.78 - 21.84) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 46.34 | Sell |
| Chaikin Money Flow: | 515638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.86 - 74.32) | Sell |
| Bollinger Bands (100): | (51.81 - 81.07) | Buy |
EOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.59 | Buy |
| 20-day SMA: | 21.49 | Buy |
| 50-day SMA: | 21.21 | Buy |
| 200-day SMA: | 20.49 | Buy |
| 8-day EMA: | 21.57 | Buy |
| 20-day EMA: | 21.5 | Buy |
| 50-day EMA: | 21.36 | Buy |
| 200-day EMA: | 20.46 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.58 | Sell |
| 20-day SMA: | 72.92 | Sell |
| 50-day SMA: | 73.99 | Sell |
| 200-day SMA: | 47.03 | Buy |
| 8-day EMA: | 72.53 | Sell |
| 20-day EMA: | 73.04 | Sell |
| 50-day EMA: | 71.92 | Buy |
| 200-day EMA: | 53.13 | Buy |
Eaton Vance Enhanced Equity Income Fund II Earnings Growth & EOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
Eaton Vance Enhanced Equity Income Fund II Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||